Regeneron Pharmaceuticals, Inc. (REGN)

NASDAQ: REGN · Real-Time Price · USD

718.36

-4.44 (-0.61%)

At close: Dec 5, 2025, 4:00 PM EST

721.00

+2.64 (0.37%)

After-hours: Dec 5, 2025, 7:45 PM EST

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Net Product Sales Revenue	6.64B	7.63B	Log In	Log In	Log In	Upgrade
Sanofi Collaboration Revenue	-	-	Log In	Log In	Log In	Upgrade
Other Collaboration Revenue	-	-	Log In	Log In	Log In	Upgrade
Total Collaboration Revenue	6.97B	6.06B	Log In	Log In	Log In	Upgrade
Other Product Revenue	643.40M	515.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	14.25B	14.20B	Log In	Log In	Log In	Upgrade